TSCRE: a comprehensive database for tumor-specific cis-regulatory elements.

IF 3.4 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
NAR cancer Pub Date : 2024-01-11 eCollection Date: 2024-03-01 DOI:10.1093/narcan/zcad063
Guanjie Peng, Bingyuan Liu, Mohan Zheng, Luowanyue Zhang, Huiqin Li, Mengni Liu, Yuan Liang, Tianjian Chen, Xiaotong Luo, Xianping Shi, Jian Ren, Yueyuan Zheng
{"title":"TSCRE: a comprehensive database for tumor-specific <i>cis</i>-regulatory elements.","authors":"Guanjie Peng, Bingyuan Liu, Mohan Zheng, Luowanyue Zhang, Huiqin Li, Mengni Liu, Yuan Liang, Tianjian Chen, Xiaotong Luo, Xianping Shi, Jian Ren, Yueyuan Zheng","doi":"10.1093/narcan/zcad063","DOIUrl":null,"url":null,"abstract":"<p><p><i>Cis</i>-regulatory elements (CREs) and super <i>cis-</i>regulatory elements (SCREs) are non-coding DNA regions which influence the transcription of nearby genes and play critical roles in development. Dysregulated CRE and SCRE activities have been reported to alter the expression of oncogenes and tumor suppressors, thereby regulating cancer hallmarks. To address the strong need for a comprehensive catalogue of dysregulated CREs and SCREs in human cancers, we present TSCRE (http://tscre.zsqylab.com/), an open resource providing tumor-specific and cell type-specific CREs and SCREs derived from the re-analysis of publicly available histone modification profiles. Currently, TSCRE contains 1 864 941 dysregulated CREs and 68 253 dysregulated SCREs identified from 1366 human patient samples spanning 17 different cancer types and 9 histone marks. Over 95% of these elements have been validated in public resources. TSCRE offers comprehensive annotations for each element, including associated genes, expression patterns, clinical prognosis, somatic mutations, transcript factor binding sites, cancer-type specificity, and drug response. Additionally, TSCRE integrates pathway and transcript factor enrichment analyses for each study, enabling in-depth functional and mechanistic investigations. Furthermore, TSCRE provides an interactive interface for users to explore any CRE and SCRE of interest. We believe TSCRE will be a highly valuable platform for the community to discover candidate cancer biomarkers.</p>","PeriodicalId":94149,"journal":{"name":"NAR cancer","volume":"6 1","pages":"zcad063"},"PeriodicalIF":3.4000,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10782923/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NAR cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/narcan/zcad063","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Cis-regulatory elements (CREs) and super cis-regulatory elements (SCREs) are non-coding DNA regions which influence the transcription of nearby genes and play critical roles in development. Dysregulated CRE and SCRE activities have been reported to alter the expression of oncogenes and tumor suppressors, thereby regulating cancer hallmarks. To address the strong need for a comprehensive catalogue of dysregulated CREs and SCREs in human cancers, we present TSCRE (http://tscre.zsqylab.com/), an open resource providing tumor-specific and cell type-specific CREs and SCREs derived from the re-analysis of publicly available histone modification profiles. Currently, TSCRE contains 1 864 941 dysregulated CREs and 68 253 dysregulated SCREs identified from 1366 human patient samples spanning 17 different cancer types and 9 histone marks. Over 95% of these elements have been validated in public resources. TSCRE offers comprehensive annotations for each element, including associated genes, expression patterns, clinical prognosis, somatic mutations, transcript factor binding sites, cancer-type specificity, and drug response. Additionally, TSCRE integrates pathway and transcript factor enrichment analyses for each study, enabling in-depth functional and mechanistic investigations. Furthermore, TSCRE provides an interactive interface for users to explore any CRE and SCRE of interest. We believe TSCRE will be a highly valuable platform for the community to discover candidate cancer biomarkers.

TSCRE:肿瘤特异性顺式调节元件综合数据库。
顺式调控元件(CRE)和超顺式调控元件(SCRE)是非编码 DNA 区域,它们影响附近基因的转录,在发育过程中发挥着关键作用。据报道,CRE 和 SCRE 活性失调会改变癌基因和肿瘤抑制因子的表达,从而调节癌症的特征。为了满足对人类癌症中调控失调的 CRE 和 SCRE 的综合目录的强烈需求,我们推出了 TSCRE (http://tscre.zsqylab.com/),这是一个开放的资源,提供肿瘤特异性和细胞类型特异性的 CRE 和 SCRE,这些 CRE 和 SCRE 是通过对公开的组蛋白修饰图谱进行再分析而得到的。目前,TSCRE 包含 1 864 941 个失调的 CRE 和 68 253 个失调的 SCRE,它们是从 1366 个人类患者样本中鉴定出来的,涉及 17 种不同的癌症类型和 9 种组蛋白标记。其中 95% 以上的元素已在公共资源中得到验证。TSCRE 为每个元素提供全面的注释,包括相关基因、表达模式、临床预后、体细胞突变、转录因子结合位点、癌症类型特异性和药物反应。此外,TSCRE 还整合了每项研究的通路和转录因子富集分析,可进行深入的功能和机理研究。此外,TSCRE 还为用户提供了一个交互式界面,以探索任何感兴趣的 CRE 和 SCRE。我们相信,TSCRE 将成为社区发现候选癌症生物标记物的极具价值的平台。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.90
自引率
0.00%
发文量
0
审稿时长
13 weeks
期刊介绍:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信